Fibroblast growth factor receptor 3 pseudogene 5 (FGFR3P5)

FGFR3P5 is a member of the pseudogene family related to FGFR3, located in the human genome. Pseudogenes such as FGFR3P5 are DNA sequences similar to known genes (FGFR3 in this case) but do not code for functional proteins. While some pseudogenes can regulate the expression of related genes through non-coding RNA functions or gene regulation mechanisms, there is no evidence that FGFR3P5 itself encodes a receptor, participates in signal transduction, or acts as a functional drug target. The official drug target relevant to cancer and other diseases remains "Fibroblast growth factor receptor 3" (FGFR3)[3]. If you require data on a recognized receptor or drug target, refer to FGFR3—the protein-coding gene, not the pseudogene. Note: If your context demands information about a protein-coding therapeutic target, refer instead to "Fibroblast growth factor receptor 3 (FGFR3)", which is a receptor tyrosine kinase involved in cell growth, proliferation, and implicated in several diseases including cancer[1][3]. FGFR3 is a validated therapeutic target with approved inhibitors and clearly defined disease roles. The entry FGFR3P5 is thus not suitable for structured target annotation or drug development use; it is not a canonical or actionable therapeutic target.